Back to Authors

Frassetto, Lynda

https://orcid.org/0000-0002-4199-019X

Mayo Clinic

University of California, San Francisco

Citations 3

Neural origin plasma exosomes provide novel biomarkers for brain insulin resistance in Alzheimer's disease (S33.003)
Kapogiannis, Dimitrios , Boxer, Adam L. , Biragyn, Arya , Masharani, Umesh , Frassetto, Lynda , Petersen, Ronald, Miller, Bruce E. , Goetzl, Edward J. , Abner, Erin L. , Miller, Bruce

Neurology | December 6, 2023 | Volume: 84 | Issue: 14_supplement | Pages: No page available

10.1212/wnl.84.14_supplement.s33.003 Get It

Neural origin plasma exosomes provide novel biomarkers for brain insulin resistance in Alzheimer's disease (I11-5B)
Kapogiannis, Dimitrios , Boxer, Adam L. , Biragyn, Arya , Masharani, Umesh , Frassetto, Lynda , Petersen, Ronald, Miller, Bruce E. , Goetzl, Edward J. , Abner, Erin L. , Miller, Bruce

Neurology | December 6, 2023 | Volume: 84 | Issue: 14_supplement | Pages: No page available

10.1212/wnl.84.14_supplement.i11-5b Get It

Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural‐derived blood exosomes of preclinical Alzheimer's disease
Kapogiannis, Dimitrios , Boxer, Adam L. , Biragyn, Arya , Masharani, Umesh , Frassetto, Lynda , Petersen, Ronald C. , Goetzl, Edward J. , Schwartz, Janice B. , Abner, Erin L. , Miller, Bruce L.

The FASEB Journal | October 24, 2014 | Volume: 29 | Issue: 2 | Pages: 589-596

10.1096/fj.14-262048 Get It

ABSTRACT Insulin resistance causes diminished glucose uptake in similar regions of the brain in Alzheimer's disease (AD) and type 2 diabetes mellitus (DM2). Brain tissue studies suggested that insulin resistance is caused by low insulin receptor signaling attributable to its abnormal association with more phospho (P)‐serine‐type 1 insulin receptor substrate (IRS‐1) and less P‐tyrosine‐IRS‐1. Plasma exosomes enriched for neural sources by immunoabsorption were obtained once from 26 patients with AD, 20 patients with DM2, 16 patients with frontotemporal dementia (FTD), and matched case control subjects. At 2 time points, they were obtained from 22 others when cognitively normal and 1 to 10 yr later when diagnosed with AD. Mean exosomal levels of extracted P‐serine 312‐IRS‐1 and P‐pan‐tyrosine‐IRS‐1 by ELISA and the ratio of P‐serine 312‐IRS‐1 to P‐pan‐tyrosine‐IRS‐1 (insulin resistance factor, R) for AD and DM2 and P‐serine 312‐IRS‐1 and R for FTD were significantly different from those for case control subjects. The levels of R for AD were significandy higher than those for DM2 or FTD. Stepwise discriminant modeling showed correct classification of 100% of patients with AD, 97.5% of patients with DM2, and 84% of patients with FTD. In longitudinal studies of 22 patients with AD, exosomal levels of P‐serine 312‐IRS‐1, P‐pan‐tyrosine‐IRS‐1, and R were significantly different 1 to 10 yr before and at the time of diagnosis compared with control subjects. Insulin resistance reflected in R values from this blood test is higher for patients with AD, DM2, and FTD than case control subjects; higher for patients with AD than patients with DM2 or FTD; and accurately predicts development of AD up to 10 yr prior to clinical onset.—Kapogiannis, D., Boxer, A., Schwartz, J. B., Abner, E. L., Biragyn, A., Masharani, U., Frassetto, L., Petersen, R. C., Miller, B. L., Goetzl, E. J. Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural‐derived blood exosomes of preclinical Alzheimer's disease. FASEB J . 29, 589‐596 (2015). www.fasebj.org